Joseph A Mcnamara, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 20977 Route 68, Clarion, PA 16214 Phone: 814-745-2288 |
Dr. James Louis Rutkowski, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 35 South Second Ave, Clarion, PA 16214 Phone: 814-226-8690 Fax: 814-226-9084 |
Dr. Kevin Lee Moore, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 160 S 2nd Ave, Suite B, Clarion, PA 16214 Phone: 814-226-6321 Fax: 814-226-6353 |
Dr. John Robert Reed, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 30 Pinnacle Dr, Clarion, PA 16214 Phone: 814-223-9906 Fax: 814-223-9912 |
Joshua M Polacek Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 35 S 2nd Ave, Clarion, PA 16214 Phone: 814-226-8690 |
Jeremy M Jewell, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 22808 Route 68, Clarion, PA 16214 Phone: 814-223-9968 Fax: 814-223-9967 |
Dr. Matthew Leon Kulinski, DMD, DC Dentist Medicare: Not Enrolled in Medicare Practice Location: 30 Pinnacle Dr, Clarion, PA 16214 Phone: 814-223-9906 |
Dr. Drew V Hawk, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 1299 Greenville Pike, Clarion, PA 16214 Phone: 814-227-2160 Fax: 814-227-1933 |
News Archive
Advances in surgical options for end-stage ankle arthritis have prompted the American College of Foot and Ankle Surgeons to issue a position statement on the use of total ankle replacement surgery as an option for some patients with painful arthritis.
Researchers at the California Institute of Technology in Pasadena have developed a software tool called "Variant Database" that has detected an emerging lineage of severe acute respiratory coronavirus 2 (SARS-CoV-2) isolates in New York.
Women with higher levels of PFAS in their system may be 20% more likely to stop breastfeeding early, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today reported financial results for the three and twelve months ended December 31, 2009.
› Verified 3 days ago